Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03089970
Other study ID # 637013
Secondary ID 1K23HL127185-01A
Status Completed
Phase
First received
Last updated
Start date February 1, 2017
Est. completion date September 1, 2020

Study information

Verified date August 2021
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Respiratory virus infections cause a majority of asthma exacerbations in the fall to spring months. Current diagnostic platforms for respiratory viruses have limitations including cost, availability, and invasiveness. The use of noninvasive breath collection to analyze breath metabolites may be used to differentiate virus-infected asthmatics from other causes of acute asthma exacerbations.


Recruitment information / eligibility

Status Completed
Enrollment 19
Est. completion date September 1, 2020
Est. primary completion date March 10, 2020
Accepts healthy volunteers No
Gender All
Age group 12 Years and older
Eligibility Inclusion Criteria: - Asthma, Age =12, Symptoms/signs of an early asthma exacerbation, Ability to provide exhaled breath condensate (EBC) x15 min, Body mass index (BMI) =18 Exclusion Criteria: - Chronic lung diseases other than asthma (e.g., chronic obstructive pulmonary disease [COPD], lung cancer, fibrotic lung disease, etc.), Smoking in the past 7 days, Eating or non-clear liquids <4 hrs prior to EBC collection, Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Exhaled breath condensate collection
Breath from humans is cooled, condensed, and collected

Locations

Country Name City State
United States University of California Davis Medical Ceneter Sacramento California

Sponsors (2)

Lead Sponsor Collaborator
University of California, Davis National Heart, Lung, and Blood Institute (NHLBI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Breath metabolite differences between groups Metabolites from breath will be identified and quantified using gas chromatography-mass spectrometry; these will be compared between groups. Specific breath metabolites include isoprostane, linear and branched alkanes (C6-C9), alcohols, and thiol-containing moieties. However, we will also measure metabolites in an un-targeted manner. 36 months